glp-1 suicide US FDA removes suicidal thoughts warning from weight-loss drugs FDA requests removal of suicide
Description
Metabolic effects: For patients with type 2 diabetes, blood glucose levels typically begin rising as the medication's insulinotropic and glucagon-suppressing effects wane
Clinical trials show approximately 2040% of total weight lost with GLP-1 medications includes lean mass, comparable to dietary restriction and bariatric surgery
Maintaining results requires either continued medication use or significant, sustained lifestyle changes

Semin Nephrol 27:130143

The patient required treatment and monitoring in an ICU to make a full recovery, they write

Diabetes Research and Clinical Practice , 199, 110634
